中文 | English
Return
Total: 412 , 1/42
Show Home Prev Next End page: GO
Author:(Zhi-Fei CHEN)

2.Literature review on premarketing and postmarketing evidence of xiyanping injection.

Zhi-Fei WANG ; Xiao CHEN ; Wen ZHANG ; Yan-Ming XIE

China Journal of Chinese Materia Medica 2014;39(18):3637-3640

5.Diagnosis and treatment of lacrimal passage obstruction by lacrimal endoscope.

Zhi, WANG ; Yukan, HUANG ; Wen, CHEN ; Wei, CHEN ; Mingchang, ZHANG ; Fei, CHEN

Journal of Huazhong University of Science and Technology (Medical Sciences) 2007;27(5):593-7

6.The mechanism of toxicity enhancement with the combination of Flos Genkwa and Radix et Rhizoma Glycyrrhizae based on the solubilization of glycyrrhizic acid

Yu-qin YANG ; Fei-fei LI ; Shan CHEN ; Zhi-jia WANG ; Peng-long WANG ; Hai-min LEI

Acta Pharmaceutica Sinica 2021;56(9):2561-2566

7.SAR of benzoyl sulfathiazole derivatives as PTP1B inhibitors.

Wen-Wen YIN ; Zheng CHEN ; Yan-Bo TANG ; Fei YE ; Jin-Ying TIAN ; Zhi-Yan XIAO

Acta Pharmaceutica Sinica 2014;49(5):632-638

8.Cloning and functional characterization of a cDNA encoding isopentenyl diphosphate isomerase involved in taxol biosynthesis in Taxus media.

Tian SHEN ; Fei QIU ; Min CHEN ; Xiao-zhong LAN ; Zhi-hua LIAO

Acta Pharmaceutica Sinica 2015;50(5):621-626

9.The clinical observation of oxaliplatin combined with capecitabin for patients with advanced colorectal cancer

Xin-Jian RUAN ; Jian-Fei WANG ; Zhi GUO ; Zhao-Liang CHEN ; Xia ZHANG ;

Cancer Research and Clinic 2000;0(06):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 412 , 1/42 Show Home Prev Next End page: GO